An observational study in Normal and Ocular Pathology, sponsored by Optovue. Completed at 2 sites in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-09-28.
Sponsored by Optovue · Observational
To demonstrate clinical substantial equivalence of iVue as comparable to commercially available RTVue.
Optovue is the lead sponsor of 16 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Volunteers with various ocular pathology or no ocular pathology.
Inclusion Criteria:
Normal results from clinical exam and free of ocular pathology.
Clinical exam results consistent with retina pathology
Clinical exam results consistent with glaucoma and visual field defects consistent with glaucoma.
Clinical exam results consistent with cornea pathology.
thickness of ocular structures
This study is completed, as verified in Nov 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Optovue